Possible mechanisms explaining the association between DM and an increased risk for COVID-19 severity may be found in a higher Angiotensin-converting enzyme 2 (ACE2) expression in patients with DM [15], higher levels of TNFα, and lower levels of the anti-inflammatory cytokine, IL-10 [16]. This evidence concerns the gene ACE2 and COVID-19.